PolyPid Ltd - PYPD Company Short-Term Debt

Graphic logo of PolyPid Ltd. (PYPD)

PolyPid Ltd. (PYPD) faces the threat of D-PLEX test failures and a dependence on the FDA verdict amid a capital shortage. Risks are amplified by potential regulatory rejection and competition from low-cost therapy methods. The company is currently implementing a local antibiotic delivery system in surgery. The level of short-term liabilities reflects debt dynamics, with the indicator currently at 0.00.

PYPD (polypid.com) Company Short-Term Debts history from 07/04/2022 to 10/28/2026

PolyPid Ltd - analytical breakdowns and key metrics (PYPD)

- price and consensus price forecast:
Price Chart PolyPid Limited|PYPD - Fair Value Consensus
- market capitalization data:
Market Value PolyPid Ltd.|PYPD - Real Price to Acquire Entire Company
- book capitalization data:
Book Value per Share PolyPid|PYPD - Book Capitalization|Market Cap to Net Assets Ratio polypid.com|PYPD - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital PolyPid Ltd.|PYPD - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity PolyPid Limited|PYPD - Company Aggregate Debt|Debts to Book Capitalization PolyPid Ltd.|PYPD - Long-Term Liabilities|Company Short-Term Debts PolyPid
Analysis of all company metrics:PYPD, polypid.com
Product sample of PolyPid Limited

Investors in PolyPid Ltd. (PYPD) must evaluate the issuer's financial stability against a backdrop of regulatory risks and limited resources. By analyzing the company's short-term debt, you measure the volume of obligations maturing within one year, which is critical for preventing cash flow gaps should technology approvals be delayed. The trend in the company's short-term debt allows for liquidity forecasting and protects capital from sudden funding shortages.

Competitors of PolyPid Ltd. (PYPD)

Company Short-Term Debt Summit Therapeutics Inc. (SMMT)|MRNA: Company Short-Term Loans and Borrowings|PCVX (Vaxcyte Corp) - Company Short-Term Debt|Tarsus Corp (TARS) - Company Current Liabilities|CRMD (CorMedix Inc.) - Company Short-Term Debts|Company Short-Term Debts serestherapeutics.com (MCRB)|Spero Therapeutics, Inc. (SPRO) - Company Current Liabilities|Company Short-Term Loans and Borrowings scynexis.com (SCYX)|Company Short-Term Debts ANTX|YS Biopharma Co., Ltd. - Short-Term Debt Volume|Iterum Therapeutics, plc (ITRM) - Company Short-Term Debt|PHGE - Company Short-Term Indebtedness|Company Short-Term Debts soligenix.com (SNGX)|60 Degrees Pharmaceuticals, Inc. (SXTP) - Current Liabilities|Company Short-Term Debts OGEN (Oragenics, Inc.)|Short-Term Debt Onconetix Corporation|Company Short-Term Debts OPGN (OpGen, Inc.)